Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study.

Background: Mesenchymal stem cells (MSCs) with their potential to differentiate into mesodermal and non-mesodermal lineages have several immunomodulatory characteristics. These properties make them promising tools in cell and gene therapy.

Objective: To evaluate the potential therapeutic applications of autologous MSC in improving clinical manifestations of MS patients.